The Wilms’ tumor (WT1) gene expression correlates with the International Prognostic Scoring System (IPSS) score in patients with myelofibrosis and it is a marker of response to therapy

The Wilms tumor gene WT1 is a useful marker of clonal hematopoiesis and it has been shown to be a good marker of residual disease and it reflects the response to therapy. Although myelofibrosis is characterized by mutations of JAK2 and calreticulin (CALR), these mutations are not useful to monitor r...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Med
Main Authors: Gallo, Daniela, Nicoli, Paolo, Calabrese, Chiara, Gaidano, Valentina, Petiti, Jessica, Rosso, Valentina, Signorino, Elisabetta, Carturan, Sonia, Bot‐Sartor, Giada, Volpe, Gisella, Frassoni, Francesco, Saglio, Giuseppe, Cilloni, Daniela
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2016
Assuntos:
Commentary
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4867666/
https://ncbi.nlm.nih.gov/pubmed/27167495
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.735
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados